i think the sentient connectction was alluded to by a long...

First 236 Last

Share
Profile

Follow
Mlc2318

6,008 Posts.

751

29/11/18

20:04

Post #: 36694683
Share

Originally posted by TheGekko: ↑

I was very surprised AGY used a 10% discount rate and yes that part of the PEA is conservative, but it could be argued that other parts of the PEA offset that conservatism as pointed out by Help_me. I am not here to get in a stoush. As you know I am an LPI holder and most of us long-termers over there are well under water - many of us averaging down this year, but still under water. There are many AGYers who are still well in the money, but others that are not. Let's hope all of us get IN the money.

I will make one point and I am going to be very frank here. I think AGY's best chance to increase the probability of long term success is to do a deal with Sentient. OK, I am not telling you guys and gals anything new, but I think Jerko's visit to see the Argentinian President would have included a word or two to Government officials about Sentient real-estating and doing little else - which they are. AGY and Sentient both have leverage, one a process solution and the other brine and lots of it. Surely sense will prevail and that would remove some of the uncertainty which exists in the Rincon project and all projects at various stages - LPI's Maricunga project is no different - I have a glass-half full belief in its future, but their are still plenty of risks.

Good luck to you all.

Expand

i think the sentient connectction was alluded to by a long term holder some months back ... it actually makes sense ( i also hold LPi)

AGY Price at posting: 18.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 71 more messages in this thread...

First 236 Last

Add AGY (ASX) to my watchlist

(20min delay)
Last 3.9¢		Change 0.001(2.63%)		Mkt cap ! $56.78M

Open	High	Low	Value	Volume
4.0¢	4.1¢	3.9¢	$303.9K	7.541M

Buyers (Bids)

No.	Vol.	Price($)
3	304999	3.9¢

Sellers (Offers)

Price($)	Vol.	No.
4.0¢	25000	1

View Market Depth

No.	Vol.	Price($)
3	304999	0.039
7	563206	0.038
5	648648	0.037
22	2110708	0.036
25	2513178	0.035

Price($)	Vol.	No.
0.040	25000	1
0.041	406425	2
0.042	751292	7
0.043	1956941	3
0.044	1035285	9

Last trade - 16.10pm 07/10/2024 (20 minute delay)

AGY (ASX) Chart

i think the sentient connectction was alluded to by a long...

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

i think the sentient connectction was alluded to by a long...

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News